| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/13/2006 | EP1699759A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 09/13/2006 | EP1699527A1 High-density lipoprotein coated medical devices |
| 09/13/2006 | EP1699495A2 Conjugates of angiotensin ii and an imaging moiety |
| 09/13/2006 | EP1699479A1 Synthetic protein as tumor-specific vaccine |
| 09/13/2006 | EP1699478A2 Treating inflammation using a biological agent that causes cells to release cytokine receptors |
| 09/13/2006 | EP1699477A2 Compositions for use in the treatment of mutant receptor tyrosine kinase driven cellular proliferative diseases |
| 09/13/2006 | EP1699476A1 Method for preventing and treating diabetes using dg119 |
| 09/13/2006 | EP1699473A2 Solvent for biogenic active pharmaceutical ingredients |
| 09/13/2006 | EP1699472A1 Pharmaceutical active agent against breast cancer |
| 09/13/2006 | EP1699471A1 Pharmaceutical active ingredient against hepatitis |
| 09/13/2006 | EP1699470A2 Biological active blood serum obtained by electrostimulation |
| 09/13/2006 | EP1699469A2 Recombinant factor viii having increased specific activity |
| 09/13/2006 | EP1699460A2 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 09/13/2006 | EP1699456A1 Use of macrolides for treating or preventing airflow obstruction |
| 09/13/2006 | EP1699437A2 Method for preparing solid dosage form of desmopressin |
| 09/13/2006 | EP1699418A2 Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 09/13/2006 | EP1699398A2 Enhancement of immune responses |
| 09/13/2006 | EP1625152B1 Peptides modulating the activity of the engrailed transcription factor |
| 09/13/2006 | EP1453527B1 Method for obtaining oestrogen from mare urine |
| 09/13/2006 | EP1442050B1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 09/13/2006 | EP1366074B1 Modified granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 09/13/2006 | EP1363944B1 High-affinity antagonists of elr-cxc chemokines |
| 09/13/2006 | EP1360504B1 Method for screening compounds for activity in treating an osteoclast related bone disease |
| 09/13/2006 | EP1355655B1 Compositions and methods for improving kidney function |
| 09/13/2006 | EP1343486B1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 09/13/2006 | EP1305635B1 Methods to identify compounds that modulate rage |
| 09/13/2006 | EP1305406B1 Modulation of gamma-secretase activity |
| 09/13/2006 | EP1303295B1 Caseinoglycomacropeptide for inhibiting adhesion of the pathogenic flora of the skin |
| 09/13/2006 | EP1284720B1 L-fmau for the treatment of hepatitis delta viral infection |
| 09/13/2006 | EP1282643B1 Anti-inflammatory compounds and uses thereof |
| 09/13/2006 | EP1274406B1 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 09/13/2006 | EP1224288B1 Processed human chemokine phc-1 |
| 09/13/2006 | EP1221954B1 Methods for identifying inhibitors of methionine aminopeptidases |
| 09/13/2006 | EP1200067B1 Method for the preparation of microparticles comprising biological material |
| 09/13/2006 | EP1196579B1 Tryptase inhibitor |
| 09/13/2006 | EP1196431B1 A substantially crystalline form of melagatran |
| 09/13/2006 | EP1196154B1 Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine |
| 09/13/2006 | EP1163272B1 Antibodies specific for cyp1b1 |
| 09/13/2006 | EP1139780B1 Method for producing granulates containing enzymes |
| 09/13/2006 | EP1094835B1 Process for manufacturing of a pharmaceutical composition comprising human apotransferrin |
| 09/13/2006 | EP1088084B1 Erythropoietin analog-human serum albumin fusion protein |
| 09/13/2006 | EP1007656B1 Modified protein kinase a-specific hybrid oligonucleotide in combination with paclitaxol and methods of their use |
| 09/13/2006 | EP0981545B1 IGFIIE/ IGFBP2 complex |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | EP0843732B1 Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
| 09/13/2006 | EP0832093B1 Expression of lipoproteins |
| 09/13/2006 | EP0811065B1 Antagonists of interleukin-15 |
| 09/13/2006 | EP0755446B1 Cardiotrophin and uses therefor |
| 09/13/2006 | CN1833171A Modulating the interaction between hgf beta chain and c-met |
| 09/13/2006 | CN1833031A Casein hydrolyzate, process for producing the same and use thereof |
| 09/13/2006 | CN1832963A Specific inhibition of allograft rejection |
| 09/13/2006 | CN1832960A Immunomodulating compositions, uses therefor and processes for their production |
| 09/13/2006 | CN1832959A Polyethelene glycol link glp-1 compounds |
| 09/13/2006 | CN1832958A Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 09/13/2006 | CN1832763A Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects |
| 09/13/2006 | CN1832755A Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections |
| 09/13/2006 | CN1832754A Formulation of albumin-free erythropoietin |
| 09/13/2006 | CN1832753A Ghrelin analogs |
| 09/13/2006 | CN1832752A Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques |
| 09/13/2006 | CN1831121A Method for structuring hybridoma cell system for anti-human monoclonal antibody of hepatitis B virus and its application |
| 09/13/2006 | CN1831012A Immunological adjuvant with immunity vegulating agent for treating and preventing diabetic from insulin-dependent |
| 09/13/2006 | CN1831004A Antiviral polypeptide from Zongdian Tuanwa frog and its application in pharmacy |
| 09/13/2006 | CN1831003A Polypeptide organic compounds and application in xenogeneic transplantation |
| 09/13/2006 | CN1831001A Bone peptide extraction, prepn. method and use thereof |
| 09/13/2006 | CN1830488A High density lipoprotein and its lipoprotein carrier used as anti coated virus medicine |
| 09/13/2006 | CN1830487A Blood vessel formation inhibitor IIM3 and its preparation method and application |
| 09/13/2006 | CN1830486A Application of pumpkin protein in preparation of medicine |
| 09/13/2006 | CN1830485A Preparation method of anti-inflammation analgesia medicine compound bone peptide injection |
| 09/13/2006 | CN1830418A Microencapsulation method of superoxide dismutase |
| 09/13/2006 | CN1274834C Man's serum albumin with man's parathormone (1-34) fusion protein and its application |
| 09/13/2006 | CN1274829C Anti EB virus resulted tumour polypeptide, and its use and preparing method |
| 09/13/2006 | CN1274821C Modular transport systems for molecular substances and production and use thereof |
| 09/13/2006 | CN1274717C Immune suppression fusion protein, its coded nucleic acid and application |
| 09/13/2006 | CN1274715C Memno peptides, a process for their preparation and their use |
| 09/13/2006 | CN1274713C Inhibitors of kallikrein |
| 09/13/2006 | CN1274712C Peptide derivative, and pharmaceutically acceptable salt thereof, process for producing the same, and use thereof |
| 09/13/2006 | CN1274365C Medicinal compositions for angiogenic therapy |
| 09/13/2006 | CN1274363C Auxiliary therapeutic agent for C type hepatitis |
| 09/13/2006 | CN1274362C Medicine for preventing and treating AIDS |
| 09/13/2006 | CN1274361C Soybean peptide, its preparation and application |
| 09/13/2006 | CN1274294C Novel cyclosporin analog microemulsion preconcentrates |
| 09/13/2006 | CN1274235C Anti-dental caries chewing gum and preparation |
| 09/12/2006 | US7105673 Cardioprotective phosphonates and malonates |
| 09/12/2006 | US7105655 Stabilization of envelope glycoprotein trimers by disulfide bonds introduced into a gp41 glycoprotein ectodomain |
| 09/12/2006 | US7105653 Polypeptide comprising human interleukin-2 mutein with amino acid substitutions; , activates T cells over Natural Killer Cells; reduced toxicity; vectors, transformed host cells |
| 09/12/2006 | US7105651 Nucleotide sequences coding polypeptide for use in the treatment of cancer, inflammation and infection; for use as pesticide and antibiotic |
| 09/12/2006 | US7105644 Secreted protein HHTLF25 antibodies |
| 09/12/2006 | US7105641 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents |
| 09/12/2006 | US7105637 Kits for detection/diagnosis of Smith-Lemli-Optiz syndrome |
| 09/12/2006 | US7105636 SARA proteins |
| 09/12/2006 | US7105635 Cyclic beta-sheet peptides useful as apoptotic/cytotoxic cancer agents |
| 09/12/2006 | US7105496 Analyzing tumors; bone disorders; antidiabetic agents; platelet derived endothelial growth factor |
| 09/12/2006 | US7105494 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies |
| 09/12/2006 | US7105490 Methods and compositions for treating polycystic ovary syndrome |
| 09/12/2006 | US7105489 Methods and compositions for treating polycystic ovary syndrome |
| 09/12/2006 | US7105488 inhibiting a target G protein-coupled receptor (GPCR) by contacting a cell that expresses GPCR with an isolated GPCR-modulating peptide; inhibits a biological activity of GPCR by disrupting the structure; antitumor, prevents binding of a virus and subsequent infection |
| 09/12/2006 | US7105487 Animals are injected with an injection solution that contains synthetically produced FSH-releasing hormones with known sequences consisting of 10 amino acids (decapeptide) |
| 09/12/2006 | US7105486 Administering L-lysine-d-amphetamine; attention deficit hyperactivity disorder; decreasing the bioavailability of amphetamine by intravenous or intranasal administration, further limiting their abuse liability. |
| 09/12/2006 | US7105484 GDNF receptorα |
| 09/12/2006 | US7105483 Phosphinic pseudopeptide derivatives for the selective inhibition of the C-terminal active site of angiotensin I converting enzyme (ACE) |